Regis Healthcare Limited (FRA:06K1)
Germany · Delayed Price · Currency is EUR | Market Cap | 904.26M -25.4% |
| Revenue (ttm) | 817.83M +16.3% |
| Net Income | 33.72M +13.8% |
| EPS | 0.12 +14.1% |
| Shares Out | n/a |
| PE Ratio | 25.01 |
| Forward PE | 24.95 |
| Dividend | 0.11 (3.95%) |
| Ex-Dividend Date | Sep 8, 2026 |
| Volume | 113 |
| Open | 2.880 |
| Previous Close | 2.840 |
| Day's Range | 2.880 - 2.880 |
| 52-Week Range | 2.540 - 3.980 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Regis Healthcare
Regis Healthcare Limited engages in the provision of aged care services in Australia. It provides residential aged care services, including ageing-in-place, respite care, specialist dementia care, and palliative care services through the operation of aged care homes; and day therapy services. The company also offers home care services, such as personal care, nursing, help around your home, shopping, transport, companionship, overnight sleepovers, and cooking and meal preparation, as well as home maintenance, gardening, and allied health service... [Read more]
Financial Performance
In fiscal year 2026, Regis Healthcare's revenue was 1.35 billion, an increase of 16.30% compared to the previous year's 1.16 billion. Earnings were 55.69 million, an increase of 13.76%.
Financial numbers in AUD Financial StatementsNews
Regis Healthcare Shares Sink 29% As Aged Care Sector Faces Fresh Government Funding Uncertainty
Regis Healthcare shares fell 29% despite reporting record financial results, highlighting ongoing concerns over aged care funding uncertainty affecting Australia's largest aged care operators.
Australia's Regis Healthcare slumps as aged-care funding raise falls short of cost pressures
Shares of Australia's Regis Healthcare plunged nearly 35% on Thursday after the company said an increase in the government's funding rate for residential aged care fell well short of inflation across ...
Regis Healthcare Earnings Call Transcript: H2 2026
Revenue grew 16% to AUD 1.35 billion, with strong EBITDA and cash flow growth driven by acquisitions, pricing, and occupancy. Portfolio expansion and higher RAD inflows support future earnings, while cost pressures and regulatory changes remain key risks.
Regis Healthcare Earnings release: H2 2026
Regis Healthcare released its H2 2026 earnings on August 23, 2026, summarizing the period's financial results.
Regis Healthcare Slides: H2 2026
Regis Healthcare has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 23, 2026.
Regis Healthcare Annual report: H2 2026
Regis Healthcare has published its H2 2026 annual report on August 23, 2026.
ASX 200 LIVE: Darren Yip named ASX Ltd interim CEO; Woolworths warns Iran war, fuel prices to hit profit; ASX lower for eighth day
Shares lower for an eighth day; Coles dives after Woolworths warns on fuel prices; Regis Healthcare tips growth; MinRes upgrades guidance; South32 falls on Hermosa blowout. Follow live.
ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation
SYDNEY — Australian shares posted mixed results Thursday with the benchmark S&P/ASX 200 index closing down 0.57%, yet a handful of standout performers bucked the broader weakness, delivering double-di...
Regis Healthcare Shares Soar 16% on Australian Budget Aged Care Funding Boost
SYDNEY — Shares in Regis Healthcare Ltd surged more than 16% on Thursday as investors cheered a major federal budget announcement that promises significant changes to aged care funding, providing fres...
Healthcare co-founder offloads Toorak mansion in ‘stagnant’ market
Regis Healthcare co-founder Bryan Dorman has sold his grand Toorak home as buyers drag heals on big property deals.
Regis Healthcare Earnings Call Transcript: H1 2026
H1 FY2026 saw 18% revenue growth and 4% higher underlying EBITDA, driven by acquisitions and room price increases. Strong cash flow and RAD inflows support ongoing expansion, with margin pressure from funding changes expected to ease as reforms and operational efficiencies take effect.
Regis Healthcare Quarterly report: H1 2026
Regis Healthcare has published its H1 2026 quarterly earnings report on February 22, 2026.
Regis Healthcare Slides: H1 2026
Regis Healthcare has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 22, 2026.
Regis Healthcare Earnings release: H1 2026
Regis Healthcare released its H1 2026 earnings on February 22, 2026, summarizing the period's financial results.
Bain’s Estia Health hires banks for $700m-plus IPO; preps under way
Fund managers will be asked to compare Estia Health with listed peer Regis Healthcare, capitalised at around $2 billion on the ASX.
Regis Healthcare Transcript: AGM 2025
Strong FY 2025 financial results and increased dividends were reported, with a clear growth strategy targeting 10,000 beds by FY 2028 through acquisitions and developments. Key governance, funding, and sector challenges were discussed, and all resolutions were put to poll.
Regis Healthcare Slides: FY 2025
Regis Healthcare has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 17, 2025.
Regis Healthcare Earnings Call Transcript: H2 2025
Strong financial performance with revenue up 15%, EBITDA up 17%, and NPAT up 37% year-over-year, driven by high occupancy, acquisitions, and government funding. Strategic growth continues via acquisitions and greenfield developments, with a focus on operational excellence and meeting new regulatory standards.
Regis Healthcare Annual report: H2 2025
Regis Healthcare has published its H2 2025 annual report on August 24, 2025.
Regis Healthcare Slides: H2 2025
Regis Healthcare has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 24, 2025.
Regis Healthcare Earnings release: H2 2025
Regis Healthcare released its H2 2025 earnings on August 24, 2025, summarizing the period's financial results.
Why this boss negotiated a 25pc pay rise for her staff
Regis Healthcare CEO Linda Mellors says the business is bouncing back after being hammered by the pandemic and a royal commission.
Jarden launches $133m Regis Healthcare co-founder block trade
Dorman and co-founder Ian Roberts floated Regis in 2014, retaining 27 per cent each, and have waited nearly a decade to start selling.
Regis Healthcare co-founder taps Jarden for $108m selldown
Bryan Dorman would be congratulating himself that he did not cave in to a $1.85-a-share tilt from Soul Patts back in 2020.